Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection
Timotius Ivan Hariyanto, Andree Kurniawan
Obesity Medicine, doi:10.1016/j.obmed.2020.100290
Background and aims: The coronavirus disease 2019 (COVID-19) pandemic has caused a significant impact on all aspects of life. One of the comorbidities associated with severe outcome and mortality of COVID-19 is diabetes. Metformin is one of the drugs which is most commonly used for the treatment of diabetes patients. This study aims to analyze the potential benefit of metformin use in reducing the mortality rate from COVID-19 infection. Methods: We systematically searched the Google Scholar database using specific keywords related to our aims until August 3rd, 2020. All articles published on COVID-19 and metformin were retrieved. Statistical analysis was done using Review Manager 5.4 software. Results: A total of 5 studies with a total of 6937 patients were included in our analysis. Our meta-analysis showed that metformin use is associated with reduction in mortality rate from COVID-19 infections [RR 0.54 (95% CI 0.32-0.90), p = 0.02, I 2 = 54%, random-effect modelling]. Conclusion: Metformin has shown benefits in reducing the mortality rate from COVID-19 infections. Patients with diabetes should be advised to continue taking metformin drugs despite COVID-19 infection status.
References
Al-Benna, Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients, Obes Med,
doi:10.1016/j.obmed.2020.100283Bramante, Ingraham, Murray, Marmor, Hoversten et al., Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19,
doi:10.1101/2020.06.19.20135095Chen, Yang, Cheng, Chen, Peng et al., Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication, Diabetes Care,
doi:10.2337/dc20-0660Crouse, Grimes, Li, Might, Ovalle et al., Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes,
doi:10.1101/2020.07.29.20164020Hariyanto, Kurniawan, Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection, Diabetes Metab Syndr,
doi:10.1016/j.dsx.2020.07.054Hariyanto, Kurniawan, Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection, Diabetes Metab Syndr,
doi:10.1016/j.dsx.2020.07.044Huang, Lim, Pranata, Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia -a systematic review, meta-analysis, and meta-regression, Diabetes Metab Syndr,
doi:10.1016/j.dsx.2020.04.018Luo, Qiu, Liu, Liu, Zheng et al., Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis, Am. J. Trop. Med. Hyg,
doi:10.4269/ajtmh.20-0375Singh, Gupta, Ghosh, Misra, Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations, Diabetes Metab Syndr,
doi:10.1016/j.dsx.2020.04.004Wang, Van Oekelen, Mouhieddine, Del, Valle et al., A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward, J. Hematol. Oncol,
doi:10.1186/s13045-020-00934-xDOI record:
{
"DOI": "10.1016/j.obmed.2020.100290",
"ISSN": [
"2451-8476"
],
"URL": "http://dx.doi.org/10.1016/j.obmed.2020.100290",
"alternative-id": [
"S245184762030110X"
],
"article-number": "100290",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "Obesity Medicine"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.obmed.2020.100290"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2020 Elsevier Ltd. All rights reserved."
}
],
"author": [
{
"affiliation": [],
"family": "Hariyanto",
"given": "Timotius Ivan",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-5219-9029",
"affiliation": [],
"authenticated-orcid": false,
"family": "Kurniawan",
"given": "Andree",
"sequence": "additional"
}
],
"container-title": [
"Obesity Medicine"
],
"content-domain": {
"crossmark-restriction": true,
"domain": [
"clinicalkey.jp",
"clinicalkey.com",
"clinicalkey.es",
"clinicalkey.com.au",
"clinicalkey.fr",
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2020,
8,
18
]
],
"date-time": "2020-08-18T17:44:19Z",
"timestamp": 1597772659000
},
"deposited": {
"date-parts": [
[
2020,
11,
25
]
],
"date-time": "2020-11-25T06:11:48Z",
"timestamp": 1606284708000
},
"indexed": {
"date-parts": [
[
2022,
3,
28
]
],
"date-time": "2022-03-28T12:48:26Z",
"timestamp": 1648471706104
},
"is-referenced-by-count": 61,
"issn-type": [
{
"type": "print",
"value": "2451-8476"
}
],
"issued": {
"date-parts": [
[
2020,
9
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
9,
1
]
],
"date-time": "2020-09-01T00:00:00Z",
"timestamp": 1598918400000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S245184762030110X?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S245184762030110X?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "100290",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2020,
9
]
]
},
"published-print": {
"date-parts": [
[
2020,
9
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1016/j.obmed.2020.100283",
"article-title": "Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients",
"author": "Al-Benna",
"doi-asserted-by": "crossref",
"first-page": "100283",
"journal-title": "Obes Med",
"key": "10.1016/j.obmed.2020.100290_bib1",
"volume": "19",
"year": "2020"
},
{
"author": "Bramante",
"key": "10.1016/j.obmed.2020.100290_bib2",
"series-title": "Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19",
"year": "2020"
},
{
"DOI": "10.2337/dc20-0660",
"article-title": "Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication",
"author": "Chen",
"doi-asserted-by": "crossref",
"first-page": "1399",
"issue": "7",
"journal-title": "Diabetes Care",
"key": "10.1016/j.obmed.2020.100290_bib3",
"volume": "43",
"year": "2020"
},
{
"article-title": "Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes",
"author": "Crouse",
"journal-title": "medRxiv",
"key": "10.1016/j.obmed.2020.100290_bib4",
"year": "2020"
},
{
"DOI": "10.1016/j.dsx.2020.07.044",
"article-title": "Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection",
"author": "Hariyanto",
"doi-asserted-by": "crossref",
"first-page": "1429",
"issue": "5",
"journal-title": "Diabetes Metab Syndr",
"key": "10.1016/j.obmed.2020.100290_bib5",
"volume": "14",
"year": "2020"
},
{
"DOI": "10.1016/j.dsx.2020.07.054",
"article-title": "Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection",
"author": "Hariyanto",
"doi-asserted-by": "crossref",
"first-page": "1463",
"issue": "5",
"journal-title": "Diabetes Metab Syndr",
"key": "10.1016/j.obmed.2020.100290_bib6",
"volume": "14",
"year": "2020"
},
{
"DOI": "10.1016/j.dsx.2020.04.018",
"article-title": "Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression",
"author": "Huang",
"doi-asserted-by": "crossref",
"first-page": "395",
"issue": "4",
"journal-title": "Diabetes Metab Syndr",
"key": "10.1016/j.obmed.2020.100290_bib7",
"volume": "14",
"year": "2020"
},
{
"DOI": "10.4269/ajtmh.20-0375",
"article-title": "Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis",
"author": "Luo",
"doi-asserted-by": "crossref",
"first-page": "69",
"issue": "1",
"journal-title": "Am. J. Trop. Med. Hyg.",
"key": "10.1016/j.obmed.2020.100290_bib8",
"volume": "103",
"year": "2020"
},
{
"DOI": "10.1016/j.diabres.2020.108183",
"article-title": "Metformin in COVID-19: a possible role beyond diabetes",
"author": "Sharma",
"doi-asserted-by": "crossref",
"first-page": "108183",
"journal-title": "Diabetes Res. Clin. Pract.",
"key": "10.1016/j.obmed.2020.100290_bib9",
"volume": "164",
"year": "2020"
},
{
"DOI": "10.1016/j.dsx.2020.04.004",
"article-title": "Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations",
"author": "Singh",
"doi-asserted-by": "crossref",
"first-page": "303",
"issue": "4",
"journal-title": "Diabetes Metab Syndr",
"key": "10.1016/j.obmed.2020.100290_bib10",
"volume": "14",
"year": "2020"
},
{
"DOI": "10.1016/j.diabres.2020.108167",
"article-title": "COVID-19 and diabetes: is metformin a friend or foe?",
"author": "Ursini",
"doi-asserted-by": "crossref",
"first-page": "108167",
"journal-title": "Diabetes Res. Clin. Pract.",
"key": "10.1016/j.obmed.2020.100290_bib11",
"volume": "164",
"year": "2020"
},
{
"DOI": "10.1186/s13045-020-00934-x",
"article-title": "A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "94",
"issue": "1",
"journal-title": "J. Hematol. Oncol.",
"key": "10.1016/j.obmed.2020.100290_bib12",
"volume": "13",
"year": "2020"
}
],
"reference-count": 12,
"references-count": 12,
"relation": {},
"score": 1,
"short-container-title": [
"Obesity Medicine"
],
"short-title": [],
"source": "Crossref",
"subject": [
"Public Health, Environmental and Occupational Health",
"Endocrinology, Diabetes and Metabolism",
"Internal Medicine"
],
"subtitle": [],
"title": [
"Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection"
],
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
"volume": "19"
}
